UV spectrophotometric and HPLC method for quantification of ticagrelor in bulk and tablet dosage form Bairam Ravinder1, Tatapudi Hemant Kumar1,*, Gajji Neelama2, Rasheed Shaik Harun3 1Department of Pharmaceutical Analysis, Srikrupa Institute of Pharmaceutical Sciences, Siddipet-502 277 (TS), India 2Department of Pharmacognosy, Srikrupa Institute of Pharmaceutical Sciences, Siddipet-502 277 (TS), India 3Department of Pharmaceutics, Gurunanak Institute of Pharmacy, Khanapur, Telangana, 501506, India *Corresponding Author E-mail: hemkar_pharma@yahoo.co.in
Online published on 22 February, 2023. Abstract The aim of the present investigation was to develop, validate and compare a UV spectrophotometric and a high performance liquid chromatography method for estimating Ticagrelor in bulk and tablet dosage form. Spectrophotometry and high performance liquid chromatography were carried out using standard instrumental parameters, which were optimized. Both methods were validated in terms of linearity, accuracy, precision, robustness, ruggedness and stability according to the ICH guidelines. The optimized ratio of mobile phase in high performance liquid chromatography under low pressure gradient mode was 30:70 % v/v of acetonitrile:glacial acetic acid 1 % , which provide a sharp peak with a short retention time of 3.910 minutes. In UV spectrophotometric analysis iso-propyl alcohol as a solvent gave adequate molar absorptivity at a λmax of 306 nm. Results indicated that both UV spectrophotometric and high performance liquid chromatography methods were linear, precise, accurate, rugged and robust with RSD values less than 2 % and percent recovery was within the standard limits (90-110 %). Both the methods were found to be statistically non-significant at 95 % confidence intervals (p<0.05) with respect to each other. The proposed methods were found to be highly effective and could be used for quantification of Ticagrelor in bulk and a tablet formulations for routine analysis. Top Keywords UV, HPLC, Ticagrelor, Tablet dosage form, ICH. Top |